Evidence map›Paper›PMID 37027220›Full record

ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2023

Validation of the German Registry for Acute Aortic Dissection Type A Score in predicting 30-day mortality after type A aortic dissection surgery.

Marco Gemelli, Ettorino Di Tommaso, Roberto Natali, Lauren Kari Dixon, Eltayeb Mohamed Ahmed, Cha Rajakaruna, Vito D Bruno

Abstract read
In one paragraph

Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Marco GemelliCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.ORCID 0000-0003-2902-7947
Ettorino Di TommasoCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.
Roberto NataliCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.
Lauren Kari DixonCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.
Eltayeb Mohamed AhmedCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.
Cha RajakarunaCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.
Vito D BrunoCardiothoracic Surgery, Bristol Heart Institute, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK.ORCID 0000-0002-8193-9559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNo reliable scores are available to predict mortality following surgery for type A acute aortic dissection (TAAAD). Recently, the German Registry of Acute Aortic Dissection Type A (GERAADA) score has been developed. We aim to compare how the GERAADA score performs in predicting operative mortality for TAAAD to the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II.

methodsWe calculated the GERAADA score and EuroSCORE II in patients who underwent TAAAD repair at the Bristol Heart Institute. As there are no precise criteria to calculate the GERAADA score, we used 2 methods: a Clinical-GERAADA score, which evaluated malperfusion with clinical and radiological evidence, and a Radiological-GERAADA score, where malperfusion was assessed by computed tomography scan alone.

results207 consecutive patients had surgery for TAAAD, and the observed 30-day mortality was 15%. The Clinical-GERAADA score showed the strongest discriminative power with an area under the curve (AUC) of 0.80 [95% confidence interval (CI) 0.71-0.89], while the Radiological-GERAADA score had an AUC of 0.77 (95% CI 0.67-0.87). EuroSCORE II showed acceptable discriminative power with an AUC of 0.77 (95% CI 0.67-0.87).

conclusionsClinical GERAADA score performed better than the other scores and it is specific and easy to use in the context of a TAAAD. Further validation of the new criteria for malperfusion is needed.

Indexed as

Aortic AneurysmAortic DissectionAcute DiseaseHumansRegistriesRisk FactorsTreatment OutcomeAortic dissectionEuropean System for Cardiac Operative Risk EvaluationGerman Registry of Acute Type A DissectionMalperfusionRisk prediction

Identifiers

PMID37027220
PMCPMC10824554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.